Company Overview
- Website
- macrocyclics.com
- Phone
- (469) 786-6060(972) 250-2248
- Employees
- 11
- Founded in
- 1998
- Industry
- BioTech/Drugs
- NAICS Codes
-
54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services5417 - Scientific Research and Development Services54171 - Research and Development in the Physical, Engineering, and Life Sciences541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- SIC Codes
-
87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$6B
Recent News & Media
Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Chelator Platform
- Jun 13, 2025
- prnewswire.com
Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
- Mar 10, 2025
- sciencedirect.com
Metabolic PCTA-Based Shift Reagents for the Detection of Extracellular Lactate Using CEST MRI
- Feb 10, 2025
- pubs.acs.org
Side-by-Side Comparison of the In Vivo Performance of [
- Jan 30, 2025
- jnm.snmjournals.org
Y-labeled polyoxazoline combined with tumor heating potently inhibits tumor growth in mice
- Jan 25, 2025
- sciencedirect.com
Enhancing r1 Relaxivity in GdDOTA-Monoamide Complexes through Polar Group-Mediated Ordering of Second-Sphere Water Molecules | Inorganic Chemistry
- Feb 22, 2024
- pubs.acs.org
Who is Macrocyclics Inc
Macrocyclics Inc. is a manufacturer of customized chelating agents based in Plano, Texas. The company employs 11 people and generates approximately $6 million in annual revenue. Macrocyclics provides a wide range of chelating agents, including both catalog products and custom cGMP products and services. Their target customers include researchers in basic and applied research, as well as those involved in early-stage clinical development programs. They also offer expert consulting services related to chelation chemistry and bioconjugation. Macrocyclics' research and development strategy focuses on meeting the evolving needs of the medical community. Their molecular imaging platform technology is adaptable to various radionuclides for positron emission tomography (PET) and magnetic resonance imaging (MRI). The company specializes in bifunctional ligands designed for bio-targeting applications, particularly in conjunction with monoclonal antibodies and peptide fragments. For more information, visit macrocyclics.com.
Macrocyclics Inc Industry Tags
Macrocyclics Inc Tech Stack
Companies Similar to Macrocyclics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Macrocyclics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 6M | 5 | Somerville, MA | 2007 | |
| 6M | 7 | Gilbert, AZ | 2010 | |
| 6M | 22 | Houston, TX | 2003 | |
| 6M | 4 | Scottsdale, AZ | 2010 | |
| 6M | 19 | Athens, GA | 1974 |